(WHS-P72) SUCCESSFUL MANAGEMENT OF DIABETIC VENOUS ULCER WITH NOVEL ANTI-MICROBIAL HYDROGEL
Friday, May 17, 2024
7:30 AM – 5:00 PM East Coast USA Time
Methods: Patient T is a 69-year-old male patient living at high elevation in Arizona who had developed a chronic diabetic venous wound on the lower leg. Despite being a professional trauma nurse in Emergency Room Medicine for over 45 years, persistent wound status for 12 months resulted in self-referred consideration of an antimicrobial hydrogel that has been shown to effect healing in diabetics (Figure 1). The nurse-patient self-administered hydrogel once weekly until healed. Despite achieving complete and cosmetic closure after 9 weeks, Patient T accidentally reopened the wound tripping which resulted in a new deep ulcer abrasion (Figure 2). The patient followed a similar mode of treatment with self-administered hydrogel once weekly for six weeks at which time the wound was completely healed. Both wounds were treated with use of novel anti-microbial hydrogel and healed completely with full closure and acceptable cosmesis despite diabetic status and 12 months of open wound.*
Results: Patient T followed protocol for weekly administration of Floraseptic and documented the healing progress with weekly images. FloraSeptic contributed to the accelerated healing process in Patient T. All evidence of the diabetic venous ulcer wound showed closure by the end of the 30-day treatment period full closure of the wound signifying successful wound healing. (Figure 1) The second wound, or the reopened wound abrasion, showed similar closure in less than 2 months. Granulation tissue formation was observed within the first week of treatment, followed by a progressive reduction in wound size, improved tissue quality, and full closure, signifying successful wound healing. (Figure 2)
Conclusion: The application of FloraSeptic led to expedited wound healing, with complete closure. One important differentiating facet of the application was treatment for a persistent, non-healing wound in a patient with diabetes over a relatively short course with no issues of delay, seeping, or need for antibiotics. FloraSeptic, a novel and innovative wound care product, appears to offer a promising solution for healthcare providers in the management of challenging venous ulcers even amidst the additional complication of diabetes. Developed with a botanical formulation to promote healing, Floraspetic provides antimicrobial protection, and sustains a balanced and optimized pH that supports epithelialization and wound closure during the healing process. Previous evaluations in spine surgery have demonstrated reduced surgical site infections and accelerated healing, while at the same time retaining normal skin pigmentation.1
References: *FloraSeptic, BonePharm, LLC, Tampa, FL [1] Spencer T, Gorinshteyn B, Ganey T. Efficacy and Safety of Berberex Wound Cleanser on Post-Operative Surgical Incisions. Clin Surg. 2016; 1: 1196.